Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema ; volume:38 ; number:1 ; day:21 ; month:7 ; year:2023 ; pages:54-60 ; date:1.2024
Eye ; 38, Heft 1 (21.7.2023), 54-60, 1.2024
- Creator
-
Khoramnia, Ramin
Nguyen, Quan Dong
Kertes, Peter J.
Sararols Ramsay, Laura
Vujosevic, Stela
Anderesi, Majid
Igwe, Franklin
Eter, Nicole
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-023-02637-2
- URN
-
urn:nbn:de:101:1-2024031814034922630246
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khoramnia, Ramin
- Nguyen, Quan Dong
- Kertes, Peter J.
- Sararols Ramsay, Laura
- Vujosevic, Stela
- Anderesi, Majid
- Igwe, Franklin
- Eter, Nicole
- SpringerLink (Online service)
Other Objects (12)
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study